The cost-effectiveness of adjuvant chemotherapy for early breast cancer: A comparison of no chemotherapy and first, second, and third generation regimens for patients with differing prognoses

Background: The risk of recurrence following surgery in women with early breast cancer varies, depending upon prognostic factors. Adjuvant chemotherapy reduces this risk; however, increasingly effective regimens are associated with higher costs and toxicity profiles, making it likely that different...

Full description

Bibliographic Details
Main Authors: Campbell, H, Epstein, D, Bloomfield, D, Griffin, S, Manca, A, Yarnold, J, Bliss, J, Johnson, L, Earl, H, Poole, C, Hiller, L, Dunn, J, Hopwood, P, Barrett-Lee, P, Ellis, P, Cameron, D, Harris, A, Gray, A, Sculpher, M
Format: Journal article
Language:English
Published: 2011